FHTX position history
The shares of Foghorn Therapeutics (FHTX) that DAFNA Capital Management LLC reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2024 Q2: 41,850 shares, $241K, 0.06% of portfolio, New
- 2024 Q3: 37,664 shares, $351K, 0.08% of portfolio, Reduce −10.0%
- 2024 Q4: 186,717 shares, $881K, 0.22% of portfolio, Add +395.7%
- 2025 Q1: 304,752 shares, $1.1M, 0.32% of portfolio, Add +63.2%
- 2025 Q2: 300,452 shares, $1.4M, 0.39% of portfolio, Reduce −1.4%
- 2025 Q3: 126,859 shares, $620K, 0.15% of portfolio, Reduce −57.8%
- 2025 Q4: 126,859 shares, $685K, 0.16% of portfolio
- 2026 Q1: 111,859 shares, $535K, 0.12% of portfolio, Reduce −11.8%
- 2026 Q2: 111,859 shares, $546K, 0.10% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|